Sequence variability is correlated with weak immunogenicity inStreptococcus pyogenesM protein

Staphylococcus aureusinfection induces protein A–mediated immune evasion in humans

(2014) Noel T. Pauli et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development

(2014) Martina Sanderson-Smith et al.   JOURNAL OF INFECTIOUS DISEASES

Release of protein A from the cell wall of Staphylococcus aureus

(2014) S. Becker et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Novel Staphylococcal Glycosyltransferases SdgA and SdgB Mediate Immunogenicity and Protection of Virulence-Associated Cell Wall Proteins

(2013) Wouter L. W. Hazenbos et al.   PLoS Pathogens

Factor H Binds to the Hypervariable Region of Many Streptococcus pyogenes M Proteins but Does Not Promote Phagocytosis Resistance or Acute Virulence

(2013) Mattias C. U. Gustafsson et al.   PLoS Pathogens

Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study

(2012) D.J. McMillan et al.   CLINICAL MICROBIOLOGY AND INFECTION

Protein secretion and surface display in Gram-positive bacteria

(2012) O. Schneewind et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Cysteine proteinase SpeB from Streptococcus pyogenes – a potent modifier of immunologically important host and bacterial proteins

(2011) Daniel C. Nelson et al.   BIOLOGICAL CHEMISTRY

Cell-derived vesicles exposing coagulant tissue factor in saliva

(2011) R. J. Berckmans et al.   BLOOD

The Hypervariable Region of Streptococcus pyogenes M Protein Escapes Antibody Attack by Antigenic Variation and Weak Immunogenicity

(2011) Jonas Lannergård et al.   Cell Host & Microbe

Dispersal of Group A Streptococcal Biofilms by the Cysteine Protease SpeB Leads to Increased Disease Severity in a Murine Model

(2011) Kristie L. Connolly et al.   PLoS One

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci

(2011) James B. Dale et al.   VACCINE

Tissue Deposits of IgA-Binding Streptococcal M Proteins in IgA Nephropathy and Henoch-Schönlein Purpura

(2010) Roland Schmitt et al.   AMERICAN JOURNAL OF PATHOLOGY

The NH2‐Terminal Region ofStreptococcus pyogenesM5 Protein Confers Protection against Degradation by Proteases and Enhances Mucosal Colonization of Mice

(2010) Thomas A. Penfound et al.   JOURNAL OF INFECTIOUS DISEASES

New horizon of mucosal immunity and vaccines

(2009) Ichiro Takahashi et al.   CURRENT OPINION IN IMMUNOLOGY

Global emm type distribution of group A streptococci: systematic review and implications for vaccine development

(2009) Andrew C Steer et al.   LANCET INFECTIOUS DISEASES

Functional Dissection of Streptococcus pyogenes M5 Protein: the Hypervariable Region is Essential for Virulence

(2009) Johan Waldemarsson et al.   PLoS One

Structure-Based Stabilization of HIV-1 gp120 Enhances Humoral Immune Responses to the Induced Co-Receptor Binding Site

(2009) Barna Dey et al.   PLoS Pathogens

Coiled-Coil Irregularities and Instabilities in Group A Streptococcus M1 Are Required for Virulence

(2008) C. McNamara et al.   SCIENCE